Arena Pharmaceuticals, Inc. (ARNA): Price and Financial Metrics

Arena Pharmaceuticals, Inc. (ARNA): $99.99

0.06 (+0.06%)

POWR Rating

Component Grades








Add ARNA to Watchlist
Sign Up

Industry: Biotech




in industry

ARNA Price/Volume Stats

Current price $99.99 52-week high $100.00
Prev. close $99.93 52-week low $45.50
Day low $99.97 Volume 5,718,500
Day high $100.00 Avg. volume 1,561,326
50-day MA $93.21 Dividend yield N/A
200-day MA $70.04 Market Cap 6.17B

ARNA Stock Price Chart Interactive Chart >

Arena Pharmaceuticals, Inc. (ARNA) Company Bio

Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing drugs to address unmet medical needs. The company was founded in 1997 and is based in San Diego, California.

ARNA Latest News Stream

Event/Time News Detail
Loading, please wait...

ARNA Latest Social Stream

Loading social stream, please wait...

View Full ARNA Social Stream

Latest ARNA News From Around the Web

Below are the latest news stories about Arena Pharmaceuticals Inc that investors may wish to consider to help them evaluate ARNA as an investment opportunity.

Arena Pharmaceuticals GAAP EPS of -$2.54 misses by $0.31

Arena Pharmaceuticals press release (NASDAQ:ARNA): Q4 GAAP EPS of -$2.54 misses by $0.31. Cash, cash equivalents and marketable securities were $0.7B at December 31, 2021 as compared to $1.1B at December 31, 2020...

Seeking Alpha | February 23, 2022

Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates

PARK CITY, Utah, February 23, 2022--Arena Pharmaceuticals today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2021

Yahoo | February 23, 2022

SFO opens criminal probe into collapse of Arena Television

The Serious Fraud Office has opened a criminal investigation into Arena Television, a collapsed broadcaster that worked on the Euro 2020 football tournament and Glastonbury.

Yahoo | February 23, 2022

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PARK CITY, Utah, February 17, 2022--Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted to 18 new employees 18,527 inducement restricted stock units ("RSUs"). The inducement RSUs have a grant date and vesting commencement date of February 15, 2022 and were granted as inducements material to the new employees entering employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).

Yahoo | February 17, 2022

Top Merger Stocks Held By Fund Managers, Mid-Q1 2022

Each quarter, I spend some time reading Form 13F filings from hedge funds that specialize in merger arbitrage, documenting, and then analyzing which M&A stocks the funds have bought and which ones they haven't. I then compile the top 10 stocks held in these funds and share the results with...

Special Situations and Arbs on Seeking Alpha | February 15, 2022

Read More 'ARNA' Stories Here

ARNA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 49.66%
5-year 119.23%
2023 N/A
2022 0.00%
2021 20.97%
2020 69.15%
2019 16.61%

Continue Researching ARNA

Want to see what other sources are saying about Arena Pharmaceuticals Inc's financials and stock price? Try the links below:

Arena Pharmaceuticals Inc (ARNA) Stock Price | Nasdaq
Arena Pharmaceuticals Inc (ARNA) Stock Quote, History and News - Yahoo Finance
Arena Pharmaceuticals Inc (ARNA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!